BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Policy

  City Of Hope, Leading Cancer Research And Treatment Center, To Provide First-Ever FDA-Approved CAR-T Cell Therapy For Adult Patients With Certain Types Of Large B-Cell Lymphoma

  City of Hope will be one of the first authorized centers in the nation to provide axicabtagene ciloleucel, which the U.S. Food and Drug Administration (FDA) announced today is the first approved CAR-T cell therapy.

  October 18, 2017

   · 

  5 min read
• Business

  Momenta Pharmaceuticals Announces Date of Third Quarter 2017 Financial Results Conference Call and Webcast

  Management will host a conference call on that date at 10:00 a.m. EDT to discuss these results and provide an update on the company.

  October 18, 2017

   · 

  1 min read
• Business

  Pharmazz has Received Exclusive License to U.S. Patent for Treatment of Opioid Tolerance And Pain Management

  Pharmazz has received exclusive license to U.S. patent for treatment of opioid tolerance and pain management. Inadequate pain control is a major public health concern in the USA.

  October 18, 2017

   · 

  2 min read
• Business

  NeuroVive and Lund University Collaboration Receives Grant for Liver Cancer Research

  NeuroVive today announced that NeuroVive and Ramin Massoumi at Lund University have been granted 2.5 MSEK from the Swedish Foundation for Strategic Research for an Industrial PhD to study the role of cyclophilins in liver cancer.

  October 18, 2017

   · 

  4 min read
• Deals

  Bracco Imaging acquires SurgVision expanding into the innovative field of fluorescence imaging-guided surgery

  Bracco Imaging today announced the acquisition of SurgVision, a high-tech start-up focused on developing a real-time Fluorescence Image Guided Surgery platform combining targeted imaging agent and a device for efficient tumors visualization during oncology surgical procedures.

  October 18, 2017

   · 

  4 min read
• BioMidwest

  PH&S Products Release: Testing Confirms Fentanyl-Resistant Glove

  PH&S Products received notification from the ARDL that its ResQ-Grip premium nitrile examination grade gloves were successfully tested for resistance to fentanyl.

  October 18, 2017

   · 

  2 min read
• FDA

  Innovus Pharma Receives Approval From Health Canada for Vesele as a Natural Health Product

  Innovus Pharma announced that it has received approval from Health Canada to market its best-selling, clinically proven Vesele product as a Natural Health Product (“NHP”) to help improve nitric oxide production involved in symptoms of sexual dysfunction.

  October 18, 2017

   · 

  4 min read
• A Personal Letter to the Shareholders From TapImmune’s New Chief Executive Officer

  TapImmune announces a letter from the CEO.

  October 18, 2017

   · 

  7 min read
• Business

  Dr. Jan Van De Winkel Joins Hookipa As Chairman Of Its Board Of Directors

  Hookipa Biotech, a company pioneering an innovative class of immunotherapies for oncology and infectious diseases, today announced the appointment of Dr. Jan van de Winkel as Chairman of its Board of Directors.

  October 18, 2017

   · 

  4 min read
• Policy

  FDA Accepts Regulatory Submission for AstraZeneca’s LYNPARZA (Olaparib) in Metastatic Breast Cancer and Grants Priority Review

  LYNPARZA has the potential to offer a new treatment option for patients with germline BRCA-mutated, HER2-negative metastatic breast cancer.

  October 18, 2017

   · 

  13 min read